1   PREFACE
2   SCOPE AND METHODOLOGY
    2.1    OBJECTIVES OF THE STUDY
    2.2    STAKEHOLDERS
    2.3    DATA SOURCES
        2.3.1    PRIMARY SOURCES
        2.3.2    SECONDARY SOURCES
    2.4    MARKET ESTIMATION
        2.4.1    BOTTOM-UP APPROACH
        2.4.2    TOP-DOWN APPROACH
    2.5    FORECASTING METHODOLOGY
3   EXECUTIVE SUMMARY
4   JAPAN NEXT-GENERATION SEQUENCING MARKET - INTRODUCTION
    4.1    OVERVIEW
    4.2    MARKET DYNAMICS
    4.3    INDUSTRY TRENDS
    4.4    COMPETITIVE INTELLIGENCE
5   JAPAN NEXT-GENERATION SEQUENCING MARKET LANDSCAPE
    5.1    HISTORICAL AND CURRENT MARKET TRENDS 
    5.2    MARKET FORECAST (2025-2033)
6   JAPAN NEXT-GENERATION SEQUENCING MARKET - BY TECHNOLOGY
    6.1    WHOLE GENOME SEQUENCING
        6.1.1 OVERVIEW
        6.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.1.3 MARKET FORECAST (2025-2033)
    6.2    WHOLE EXOME SEQUENCING
        6.2.1 OVERVIEW
        6.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.2.3 MARKET FORECAST (2025-2033)
    6.3    TARGETED SEQUENCING & RESEQUENCING
        6.3.1 OVERVIEW
        6.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.3.3 MARKET FORECAST (2025-2033)
    6.4    RNA SEQUENCING
        6.4.1 OVERVIEW
        6.4.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.4.3 MARKET FORECAST (2025-2033)
    6.5    CHIP SEQUENCING
        6.5.1 OVERVIEW
        6.5.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.5.3 MARKET FORECAST (2025-2033)
    6.6    DE NOVO SEQUENCING
        6.6.1 OVERVIEW
        6.6.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.6.3 MARKET FORECAST (2025-2033)
    6.7    METHYL SEQUENCING
        6.7.1 OVERVIEW
        6.7.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.7.3 MARKET FORECAST (2025-2033)
    6.8    OTHERS
        6.8.1 HISTORICAL AND CURRENT MARKET TRENDS 
        6.8.2 MARKET FORECAST (2025-2033)
7   JAPAN NEXT-GENERATION SEQUENCING MARKET - BY PRODUCT 
    7.1    CONSUMABLES
        7.1.1 OVERVIEW
        7.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.1.3 MARKET FORECAST (2025-2033)
    7.2    PLATFORMS
        7.2.1 OVERVIEW
        7.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.2.3 MARKET FORECAST (2025-2033)
8   JAPAN NEXT-GENERATION SEQUENCING MARKET - BY APPLICATION
    8.1    ONCOLOGY
        8.1.1 OVERVIEW
        8.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.1.3 MARKET FORECAST (2025-2033)
    8.2    CLINICAL INVESTIGATION
        8.2.1 OVERVIEW
        8.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.2.3 MARKET FORECAST (2025-2033)
    8.3    REPRODUCTIVE HEALTH
        8.3.1 OVERVIEW
        8.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.3.3 MARKET FORECAST (2025-2033)
    8.4    HLA TYPING/IMMUNE SYSTEM MONITORING
        8.4.1 OVERVIEW
        8.4.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.4.3 MARKET FORECAST (2025-2033)
    8.5    METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT
        8.5.1 HISTORICAL AND CURRENT MARKET TRENDS 
        8.5.2 MARKET FORECAST (2025-2033)
    8.6    AGRIGENOMICS & FORENSICS
        8.6.1 HISTORICAL AND CURRENT MARKET TRENDS 
        8.6.2 MARKET FORECAST (2025-2033)
    8.7    CONSUMER GENOMICS
        8.7.1 HISTORICAL AND CURRENT MARKET TRENDS 
        8.7.2 MARKET FORECAST (2025-2033)

9   JAPAN NEXT-GENERATION SEQUENCING MARKET - BY WORKFLOW
    9.1    PRE-SEQUENCING
        9.1.1 OVERVIEW
        9.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        9.1.3 MARKET FORECAST (2025-2033)
    9.2    SEQUENCING
        9.2.1 OVERVIEW
        9.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        9.2.3 MARKET FORECAST (2025-2033)
    9.3    NGS DATA ANALYSIS
        9.3.1 OVERVIEW
        9.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        9.3.3 MARKET FORECAST (2025-2033)

   10  JAPAN NEXT-GENERATION SEQUENCING MARKET - BY END USER
    10.1    ACADEMIC RESEARCH
        10.1.1 OVERVIEW
        10.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        10.1.3 MARKET FORECAST (2025-2033)
    10.2    CLINICAL RESEARCH
        10.2.1 OVERVIEW
        10.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        10.2.3 MARKET FORECAST (2025-2033)
    10.3    HOSPITALS & CLINICS
        10.3.1 OVERVIEW
        10.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        10.3.3 MARKET FORECAST (2025-2033)
    10.4    PHARMA & BIOTECH ENTITIES
        10.4.1 HISTORICAL AND CURRENT MARKET TRENDS 
        10.4.2 MARKET FORECAST (2025-2033)
11  JAPAN NEXT-GENERATION SEQUENCING MARKET – BREAKUP BY REGION 
    11.1    KANTO REGION
        11.1.1 OVERVIEW
        11.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.1.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.1.4 MARKET BREAKUP BY PRODUCT TYPE
        11.1.5 MARKET BREAKUP BY TECHNOLOGY
        11.1.6 MARKET BREAKUP BY APPLICATION
        11.1.7 MARKET BREAKUP BY END USER
        11.1.8 KEY PLAYERS
        11.1.9 MARKET FORECAST (2025-2033)
    11.2    KANSAI/KINKI REGION
        11.2.1 OVERVIEW
        11.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.2.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.2.4 MARKET BREAKUP BY PRODUCT TYPE
        11.2.5 MARKET BREAKUP BY TECHNOLOGY
        11.2.6 MARKET BREAKUP BY APPLICATION
        11.2.7 MARKET BREAKUP BY END USER
        11.2.8 KEY PLAYERS
        11.2.9 MARKET FORECAST (2025-2033)
    11.3    CENTRAL/ CHUBU REGION
        11.3.1 OVERVIEW
        11.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.3.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.3.4 MARKET BREAKUP BY PRODUCT TYPE
        11.3.5 MARKET BREAKUP BY TECHNOLOGY
        11.3.6 MARKET BREAKUP BY APPLICATION
        11.3.7 MARKET BREAKUP BY END USER
        11.3.8 KEY PLAYERS
        11.3.9 MARKET FORECAST (2025-2033)
    11.4    KYUSHU-OKINAWA REGION
        11.4.1 OVERVIEW
        11.4.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.4.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.4.4 MARKET BREAKUP BY PRODUCT TYPE
        11.4.5 MARKET BREAKUP BY TECHNOLOGY
        11.4.6 MARKET BREAKUP BY APPLICATION
        11.4.7 MARKET BREAKUP BY END USER
        11.4.8 KEY PLAYERS
        11.4.9 MARKET FORECAST (2025-2033)
    11.5    TOHOKU REGION
        11.5.1 OVERVIEW
        11.5.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.5.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.5.4 MARKET BREAKUP BY PRODUCT TYPE
        11.5.5 MARKET BREAKUP BY TECHNOLOGY
        11.5.6 MARKET BREAKUP BY APPLICATION
        11.5.7 MARKET BREAKUP BY END USER
        11.5.8 KEY PLAYERS
        11.5.9 MARKET FORECAST (2025-2033)
    11.6    CHUGOKU REGION
        11.6.1 OVERVIEW
        11.6.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.6.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.6.4 MARKET BREAKUP BY PRODUCT TYPE
        11.6.5 MARKET BREAKUP BY TECHNOLOGY
        11.6.6 MARKET BREAKUP BY APPLICATION
        11.6.7 MARKET BREAKUP BY END USER
        11.6.8 KEY PLAYERS
        11.6.9 MARKET FORECAST (2025-2033)
    11.7    HOKKAIDO REGION
        11.7.1 OVERVIEW
        11.7.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.7.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.7.4 MARKET BREAKUP BY PRODUCT TYPE
        11.7.5 MARKET BREAKUP BY TECHNOLOGY
        11.7.6 MARKET BREAKUP BY APPLICATION
        11.7.7 MARKET BREAKUP BY END USER
        11.7.8 KEY PLAYERS
        11.7.9 MARKET FORECAST (2025-2033)
    11.8    SHIKOKU REGION
        11.8.1 OVERVIEW
        11.8.2 HISTORICAL AND CURRENT MARKET TRENDS 
        11.8.3 MARKET BREAKUP BY SEQUENCING TYPE
        11.8.4 MARKET BREAKUP BY PRODUCT TYPE
        11.8.5 MARKET BREAKUP BY TECHNOLOGY
        11.8.6 MARKET BREAKUP BY APPLICATION
        11.8.7 MARKET BREAKUP BY END USER
        11.8.8 KEY PLAYERS
        11.8.9 MARKET FORECAST (2025-2033)
12  JAPAN NEXT-GENERATION SEQUENCING MARKET – COMPETITIVE LANDSCAPE
    12.1    OVERVIEW
    12.2    MARKET STRUCTURE
    12.3    MARKET PLAYER POSITIONING
    12.4    TOP WINNING STRATEGIES
    12.5    COMPETITIVE DASHBOARD
    12.6    COMPANY EVALUATION QUADRANT
13  PROFILES OF KEY PLAYERS
    13.1    ILLUMINA, INC 
        13.1.1 BUSINESS OVERVIEW
        13.1.2 SERVICES OFFERED
        13.1.3 BUSINESS STRATEGIES
        13.1.4 SWOT ANALYSIS
        13.1.5 MAJOR NEWS AND EVENTS
    13.2    QIAGEN
        13.2.1 BUSINESS OVERVIEW
        13.2.2 SERVICES OFFERED
        13.2.3 BUSINESS STRATEGIES
        13.2.4 SWOT ANALYSIS
        13.2.5 MAJOR NEWS AND EVENTS
    13.3    BGI
        13.3.1 BUSINESS OVERVIEW
        13.3.2 SERVICES OFFERED
        13.3.3 BUSINESS STRATEGIES
        13.3.4 SWOT ANALYSIS
        13.3.5 MAJOR NEWS AND EVENTS
    13.4    BIO RAD LABORATORIES
        13.4.1 BUSINESS OVERVIEW
        13.4.2 SERVICES OFFERED
        13.4.3 BUSINESS STRATEGIES
        13.4.4 SWOT ANALYSIS
        13.4.5 MAJOR NEWS AND EVENTS
    13.5    OXFORD NANOPORE TECHNOLOGIES, INC
        13.5.1 BUSINESS OVERVIEW
        13.5.2 SERVICES OFFERED
        13.5.3 BUSINESS STRATEGIES
        13.5.4 SWOT ANALYSIS
        13.5.5 MAJOR NEWS AND EVENTS
    13.6    MYRIAD GENETICS. INC.
        13.6.1 BUSINESS OVERVIEW
        13.6.2 SERVICES OFFERED
        13.6.3 BUSINESS STRATEGIES
        13.6.4 SWOT ANALYSIS
        13.6.5 MAJOR NEWS AND EVENTS
   13.7    AGILENT TECHNOLOGIES, INC
        13.7.1 BUSINESS OVERVIEW
        13.7.2 SERVICES OFFERED
        13.7.3 BUSINESS STRATEGIES
        13.7.4 SWOT ANALYSIS
        13.7.5 MAJOR NEWS AND EVENTS
    13.8    EUROFINS SCIENTIFIC
        13.8.1 BUSINESS OVERVIEW
        13.8.2 SERVICES OFFERED
        13.8.3 BUSINESS STRATEGIES
        13.8.4 SWOT ANALYSIS
        13.8.5 MAJOR NEWS AND EVENTS

14  JAPAN NEXT-GENERATION SEQUENCING MARKET - INDUSTRY ANALYSIS
    14.1    DRIVERS, RESTRAINTS, AND OPPORTUNITIES
        14.1.1 OVERVIEW
        14.1.2 DRIVERS
        14.1.3 RESTRAINTS
        14.1.4 OPPORTUNITIES
    14.2   PORTERS FIVE FORCES ANALYSIS
        14.2.1 OVERVIEW
        14.2.2 BARGAINING POWER OF BUYERS
        14.2.3 BARGAINING POWER OF SUPPLIERS
        14.2.4 DEGREE OF COMPETITION
        14.2.5 THREAT OF NEW ENTRANTS
        14.2.6 THREAT OF SUBSTITUTES
    14.3    VALUE CHAIN ANALYSIS
15  APPENDIX